<DOC>
	<DOCNO>NCT02602847</DOCNO>
	<brief_summary>The aim study validate context liver transplantation , interest cccDNA assay technique develop team Professor Zoulim ( INSERM U1052 ) liver biopsy correlate assay cccDNA hepatitis B virus ( HBV ) viral load serum liver several group patient transplantation ( graft native liver explant ) transplantation .</brief_summary>
	<brief_title>Study Covalently Closed Circular DNA ( cccDNA ) Liver Transplant Patients With B Virus Markers</brief_title>
	<detailed_description />
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Patient register national Organ Transplant Waiting List liver transplantation Indication transplantation : Alcoholic relate disease without serum antihepatitis B core antibody ( HBc ) ( le 4 week ) OR HCV related disease without serum antiHBc antibody ( le 4 week ) OR Patients sign consent liver transplantation hepatitis B core antibody positive donor OR HBV related disease positive serum HBs antigen ( without HBV replication measure polymerase chain reaction ( PCR ) within 6 month prior transplantation ) Signed consent form Patient social cover Patient cover measure legal protection Coinfection HIV , hepatitis delta virus ( HDV ) , HBV ( control arm ) , HCV ( Test arm ) Positive serology within the4 week inclusion Patient cover measure legal protection inform consent sign</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>HBV</keyword>
	<keyword>cccDNA</keyword>
</DOC>